← Back to Search

Growth Factor

ST266 for Corneal Ulcer

Phase 2
Waitlist Available
Research Sponsored by Noveome Biotherapeutics, formerly Stemnion
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 months
Awards & highlights

Study Summary

This trial is testing a new eye drop to see if it can heal persistent eye defects. Non-healers will get the drop for 8 more weeks, and everyone will be checked 3 months after treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Success
Secondary outcome measures
Change in BCVA from Baseline
Clinical Success in Open-Label Extension
Incidence of Rescue Therapy
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ST266Experimental Treatment2 Interventions
Topical ocular application: one drop in the study eye four times a day for 8 weeks
Group II: PlaceboPlacebo Group2 Interventions
Topical ocular application: one drop in the study eye four times a day for 8 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ST266
2016
Completed Phase 2
~300

Find a Location

Who is running the clinical trial?

IQVIA BiotechIndustry Sponsor
19 Previous Clinical Trials
5,400 Total Patients Enrolled
Noveome Biotherapeutics, formerly StemnionLead Sponsor
12 Previous Clinical Trials
422 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
2022. "ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05066698.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top